Injectable Drug Delivery Devices Pipeline Assessment, 2019 – Pipeline Products under Development / Product Overview / Recent Developments – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Injectable
Drug Delivery Devices – Medical Devices Pipeline Assessment, 2019”
report has been added to ResearchAndMarkets.com’s
offering.

The report provides comprehensive information on the pipeline products
with comparative analysis of the products at various stages of
development. The report reviews major players involved in the pipeline
product development. It also provides information about clinical trials
in progress, which includes trial phase, trial status, trial start and
end dates, and, the number of trials for the key Injectable Drug
Delivery Devices pipeline products.

Scope

• Extensive coverage of the Injectable Drug Delivery Devices under
  development
• The report reviews details of major pipeline products which includes,
  product description, licensing and collaboration details and other
  developmental activities
• The report reviews the major players involved in the development of
  Injectable Drug Delivery Devices and list all their pipeline projects
• The coverage of pipeline products based on various stages of
  development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific
  to pipeline products
• Recent developments in the segment / industry.

Reasons to Buy

• Formulate significant competitor information, analysis, and insights
  to improve R&D strategies
• Identify emerging players with potentially strong product portfolio
  and create effective counter-strategies to gain competitive advantage
• Identify and understand important and diverse types of Injectable Drug
  Delivery Devices under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players
  with the most promising pipeline
• In-depth analysis of the product’s current stage of development,
  territory and estimated launch date.

Key Topics Covered:

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Injectable Drug Delivery Devices Overview

3 Products under Development

3.1 Injectable Drug Delivery Devices – Pipeline Products by Stage of
Development

3.2 Injectable Drug Delivery Devices – Pipeline Products by Segment

3.3 Injectable Drug Delivery Devices – Pipeline Products by Territory

3.4 Injectable Drug Delivery Devices – Pipeline Products by Regulatory
Path

3.5 Injectable Drug Delivery Devices – Pipeline Products by Estimated
Approval Date

3.6 Injectable Drug Delivery Devices – Ongoing Clinical Trials

4 Injectable Drug Delivery Devices – Pipeline Products under
Development by Companies

4.1 Injectable Drug Delivery Devices Companies – Pipeline Products by
Stage of Development

4.2 Injectable Drug Delivery Devices – Pipeline Products by Stage of
Development

5 Injectable Drug Delivery Devices – Companies and Product
Overview

5.1 AdrenaCard, Inc. Company Overview

5.2 Allergan Plc Company Overview

5.3 Alsensa ApS Company Overview

5.4 Antares Pharma Inc Company Overview

5.5 Aquavit Pharmaceuticals Inc Company Overview

5.6 Artemes Technologies, Inc. Company Overview

5.7 Ascendis Pharma A/S Company Overview

5.8 Ascil Proyectos SL Company Overview

5.9 ASIS Corp Company Overview

5.10 AzureBio SL Company Overview

5.11 BCWorld Pharm Co Ltd Company Overview

5.12 Becton Dickinson and Co Company Overview

5.13 Bespak Europe Ltd Company Overview

5.14 BioCorRx Inc Company Overview

5.15 BioMarin Pharmaceutical Inc Company Overview

5.16 BioRestorative Therapies Inc Company Overview

5.17 Bioxis Pharmaceuticals Company Overview

5.18 Brigham and Women’s Hospital Company Overview

5.19 Burke Pharmaceuticals LLC Company Overview

5.20 Callisyn Biomedical Inc Company Overview

5.21 Cambridge Consultants Ltd Company Overview

5.22 Camurus AB Company Overview

5.23 Case Western Reserve University Company Overview

5.24 Catalent Inc Company Overview

5.25 Cincinnati Children’s Hospital Medical Center Company Overview

5.26 Clearside BioMedical Inc Company Overview

5.27 DALI Medical Devices Ltd. Company Overview

5.28 DelSite, Inc. (Inactive) Company Overview

5.29 Drexel University Company Overview

5.30 Elcam Medical Company Overview

5.31 EmboMedics Inc Company Overview

5.32 Emergent BioSolutions Inc Company Overview

5.33 EP Global Communications Inc (Inactive) Company Overview

5.34 EP Technologies LLC Company Overview

5.35 Eveon SAS Company Overview

5.36 EyePoint Pharmaceuticals Inc Company Overview

5.37 FHC Inc Company Overview

5.38 GeneSYS-ID Inc Company Overview

5.39 Ghent University Company Overview

5.40 Globe Medical Tech Inc (Inactive) Company Overview

5.41 Inovio Pharmaceuticals Inc Company Overview

5.42 InVivo Therapeutics Corp Company Overview

5.43 Ipsen SA Company Overview

5.44 JCR Pharmaceuticals Co Ltd Company Overview

5.45 Lohmann Therapie-Systeme AG Company Overview

5.46 LyoGo Company Overview

5.47 Mallinckrodt Plc Company Overview

5.48 Mertiva AB Company Overview

5.49 Midas Pharma GmbH Company Overview

5.50 Milestone Scientific Inc Company Overview

5.51 NanoPass Technologies Ltd Company Overview

5.52 Novosanis NV Company Overview

5.53 Osteo Pharma BV Company Overview

5.54 Oval Medical Technologies Ltd Company Overview

5.55 Particle Therapeutics Ltd Company Overview

5.56 Pfizer Inc Company Overview

5.57 Portal Instruments Inc Company Overview

5.58 Queen Elizabeth Hospital Company Overview

5.59 QuiO Technologies LLC Company Overview

5.60 RepliCel Life Sciences Inc Company Overview

5.61 Rescitech Vision Pvt Ltd Company Overview

5.62 RetinaPharma Technologies Inc Company Overview

5.63 Revance Therapeutics Inc Company Overview

5.64 Roche Diagnostics International Ltd Company Overview

5.65 Sapporo Medical University School of Medicine Company Overview

5.66 Takeda Pharmaceutical Co Ltd Company Overview

5.67 TCB medical devices Company Overview

5.68 Terumo Corp Company Overview

5.69 Teva Pharmaceutical Industries Ltd Company Overview

5.70 TheraKine Inc (Inactive) Company Overview

5.71 Twin Star Medical Inc Company Overview

5.72 Unilife Corporation Company Overview

5.73 University of Calgary Company Overview

5.74 University of California San Diego Company Overview

5.75 University of California San Francisco Company Overview

5.76 University of Delaware Company Overview

5.77 University of Dundee Company Overview

5.78 University of Florida Company Overview

5.79 University of Saskatchewan Company Overview

5.80 University of Texas at Austin Company Overview

5.81 Vanderbilt University Company Overview

5.82 West Pharmaceutical Services Inc Company Overview

5.83 Windgap Medical Inc Company Overview

5.84 XERIS Pharmaceuticals Inc Company Overview

5.85 Ypsomed Holding AG Company Overview

6 Injectable Drug Delivery Devices – Recent Developments

6.1 Apr 24, 2019: Midatech Pharma: Audited financial results for the
year ended 31 December 2018

6.2 Apr 24, 2019: Alkermes appoints Industry Veteran C. Todd Nichols as
Senior Vice President of Sales and Marketing

6.3 Apr 23, 2019: Catalent invests $14 million at Its Eberbach, Germany
Softgel facility

6.4 Apr 18, 2019: Clearside Biomedical announces multiple presentations
on its Suprachoroidal Space injection platform at upcoming medical
meetings

6.5 Apr 15, 2019: Dr. Reddy’s Laboratories received the Establishment
Inspection Report (BIR) from US FDA for its Manufacturing Plant -3 at
Bachupally, Hyderabad

6.6 Apr 11, 2019: Milestone Scientific showcases the CompuFlo Epidural
Instrument at ASRA 2019

6.7 Apr 11, 2019: Catalent Celebrates opening of second Shanghai
facility to optimize global and local clinical supply solutions for China

6.8 Apr 10, 2019: Teva signs new $2.3 billion syndicated revolving
credit facility

6.9 Apr 08, 2019: Generex Biotechnology appoints Mark J. Prioletti to
the board of directors

6.10 Apr 08, 2019: Milestone Scientific appoints fund manager and
finance veteran Neal Goldman to Board of Directors

7 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/j5v30e

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Medical
Devices, Infusions
and Injectables